Exciting things are happening every day at VCU Massey Cancer Center. We’re saving lives and reducing suffering from cancer. We’re discovering new and better ways to prevent, diagnose and treat cancer. We’re offering opportunities for the community to join us in the progress against cancer.
Updates to outpatient care at Massey due to COVID-19
At VCU Massey Cancer Center we have implemented changes in our clinics to mitigate the coronavirus (COVID-19) situation and keep our patients and medical teams safe.
Massey awarded grant to collaborate with other elite cancer institutes on cutting-edge clinical trials
VCU Massey Cancer Center has received a UM1 sub-award from the National Cancer Institute to participate in the North American Star Consortium (NASC), an association of leading cancer institutes that collaborate on novel National Cancer Institute (NCI)-sponsored clinical trials featuring some of the most promising cancer therapies available.
Faculty members at VCU Massey Cancer Center and the VCU C. Kenneth and Dianne Wright Center for Clinical and Translational Research are expanding the curriculum for the Cancer and Molecular Medicine (CAMM) Ph.D. program at VCU to better meet the nation’s needs for the next generation of cancer scientists.
Massey researcher develops novel vaccine that is effective when combined with immunotherapy in treating colorectal cancer
In an attempt to boost the immune system’s complete ability to bombard cancer growth and progression, Julian Zhu, Ph.D., member of the Developmental Therapeutics research program at VCU Massey Cancer Center, recently developed a novel vaccine that successfully treated colorectal cancer cells in combination with immune checkpoint inhibitors, which are drugs that inhibit the function of specific proteins. In pre-clinical experiments, the combination demonstrated a complete regression without recurrence in about 60 percent of cancer cells, as indicated by research findings published in Science Advances.
VCU Massey Cancer Center director Robert Winn, M.D., recently joined the boards of directors of two influential cancer organizations, the Association of American Cancer Institutes (AACI) and LUNGevity Foundation.
VCU Massey Cancer Center researcher Charles Clevenger, M.D., Ph.D., has been named associate director for precision oncology at Massey.